We are live on ! Find out more
FLNA

Filana Therapeutics
FLNA

103 hedge funds and large institutions have $40.1M invested in Filana Therapeutics in 2025 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 20 increasing their positions, 33 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

183% more call options, than puts

Call options by funds: $4.73M | Put options by funds: $1.67M

81% more capital invested

Capital invested by funds: $22.1M → $40.1M (+$17.9M)

54% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 13

6% more funds holding

Funds holding: 97 → 103 (+6)

3.19% more ownership

Funds ownership: 25.33% → 28.52% (+3.2%)

39% less repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 33

Holders
103
Holders Change
+6
Holders Change %
+6.19%
% of All Funds
1.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
20
Increased
20
Reduced
33
Closed
13
Calls
$4.73M
Puts
$1.67M
Net Calls
+$3.06M
Net Calls Change
+$2.08M

Top Buyers

Rank Fund Capital Flow
1
Marshall Wace
Marshall Wace
United Kingdom
+$4.58M
2
6CM
683 Capital Management
New York
+$977K
3
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$517K
4
Simplex Trading
Simplex Trading
Illinois
+$332K
5
VCM
Voleon Capital Management
California
+$327K

Top Sellers

Rank Fund Capital Flow
1
Charles Schwab
Charles Schwab
California
-$550K
2
TCM
Tang Capital Management
California
-$535K
3
JP Morgan Chase
JP Morgan Chase
New York
-$441K
4
CSS
Cubist Systematic Strategies
Connecticut
-$367K
5
Millennium Management
Millennium Management
New York
-$354K
Name Holding Trade Value Shares
Change 		Change in
Stake
Rockefeller Capital Management
101
Rockefeller Capital Management
New York
$15 +$11 +5 New
HF
102
HRT Financial
New York
– -$171K -94,855 Closed
JG
103
Jain Global
New York
– -$84.8K -46,842 Closed
T. Rowe Price Associates
104
T. Rowe Price Associates
Maryland
– -$65K -35,868 Closed
AQR Capital Management
105
AQR Capital Management
Connecticut
– -$53.9K -29,782 Closed
JF
106
Jump Financial
Illinois
– -$49.5K -27,351 Closed
GSC
107
Ground Swell Capital
South Carolina
– -$30.7K -16,985 Closed
AC
108
Aristides Capital
Kentucky
– -$29.1K -16,092 Closed
Hudson Bay Capital Management
109
Hudson Bay Capital Management
Connecticut
– -$22.4K -12,355 Closed
DS
110
DRW Securities
Illinois
– -$21K -11,587 Closed
EAM
111
Empirical Asset Management
Massachusetts
– -$18.1K -10,000 Closed
SSG
112
Summit Securities Group
New York
– -$2.98K -1,647 Closed
MYIA
113
Mount Yale Investment Advisors
Colorado
– -$181 -100 Closed
EP
114
Essential Partners
California
– -$87 -48 Closed
Bessemer Group
115
Bessemer Group
New Jersey
– +$55 +24 New
1 2 3 4
5

FLNA Hedge Fund Activity: Q3 2025 in Review

103 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in Filana Therapeutics (FLNA) for Q3 2025, worth a combined $40.1M — up 81% from $22.1M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new FLNA positions and 13 closed out — a net gain of 7 holders — while 20 added to existing stakes and 33 trimmed.

The largest buyer was Marshall Wace, adding an estimated $4.58M. The largest seller was Charles Schwab, cutting an estimated $550K.

  • 103 institutional investors held Filana Therapeutics (FLNA) as of Q3 2025, up from 97 in Q2 2025.
  • Funds reported $40.1M of Filana Therapeutics stock for Q3 2025, up 81% quarter-over-quarter.
  • 20 funds opened new Filana Therapeutics positions in Q3 2025 and 13 closed out, a net change of +7 holders.
  • The largest Filana Therapeutics buyer in Q3 2025 was Marshall Wace, an estimated $4.58M added.
  • The largest Filana Therapeutics seller in Q3 2025 was Charles Schwab, an estimated $550K sold.

Based on aggregated 13F filings for Q3 2025.